BNTX

$85.76 +0.18%
Score: 59.9 BUY
LEAPs: SELL $140
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $140
Premium: $5.95
Expiry: Jan 15, 2027
Target: $132
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.59x (vs SPY: 0.9x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 16, 2026
Falling Wedge weak / forming — below our quality gate quality 51/100
A Falling Wedge is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 63% of the time; target hit in 75% of up-breaks (n=385)
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BNTX - BioNTech SE American Depositary Share

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Key Statistics

Market Cap $21B

This BNTX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BNTX's price movements with trendlines, gamma walls, and key support/resistance levels.